Articles:
Publications:

15 hours ago

Halozyme, Incyte to Collaborate on Development of Subcutaneous mAb Formulations

Halozyme, Incyte to Collaborate on Development of Subcutaneous mAb Formulations

Editor’s Take: More convenient delivery and dosing regimens, such as subcutaneous formulations, may improve the treatment experience. Halozyme Therapeutics and Incyte have a new collaboration and license agreement evaluating additional... Read more.

More from Contract Pharma

Contract Pharma 15 hours ago
Turn on Transparency.
Halozyme, Incyte to Collaborate on Development of Subcutaneous mAb Formulations
Owner: Rodman J. Zilenzinger, Jr. through Rodman Media More info
Contract Pharma 15 hours ago
Turn on Transparency.
Kalaris Therapeutics Appoints Liisa Bayko as New CFO
Owner: Rodman J. Zilenzinger, Jr. through Rodman Media More info
Contract Pharma Jul. 20, 2026
Turn on Transparency.
Samsung Biologics Launches Offer to Acquire PolyPeptide Group
Owner: Rodman J. Zilenzinger, Jr. through Rodman Media More info
More

Keep exploring Perspectify!

Create a free account and bring
more transparency to your news.

Already have an account? Log in.

Today's Media Watch

Your daily guide to the stories shaping media, journalism, and public trust.

2 hours ago
20 Countries Move to Ban Social Media for Children as Global Crackdown Grow
Neutral | Owner: Vitaliy Laptenok
2 hours ago
Russia Launches New Wave of Disinformation Against Residents of Sumy Region on TikTok
Public Broadcaster | Owner: Ukrainian Government
2 hours ago
Paramount and Warner Bros Mega Merger Paused by Judge
Public Broadcaster | Owner: British Government

Learn About Our Fact-Based Transparency System

Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.

Learn more